MEDP
Medpace Surpasses Expectations with Strong Q3 2026 Earnings and Record-Breaking New Business Awards
Medpace, a leading clinical research organization, has just reported its third quarter 2026 earnings results, exceeding expectations across various key metrics. During the company's recent conference call, CEO August Troendle highlighted the strong business environment and impressive growth achievements. The Q3 revenue reached $716 million, marking an 8.